Across TCGA pan-cancer cohorts, NBPF7 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NBPF7 data layer compared with 16 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher NBPF7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NBPF7 expression acts as an unfavorable survival marker.

ACC are the cancer types where NBPF7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.149	0.686	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: NBPF7 tumor-vs-normal RNA expression · all NBPF7 data types